Increased Survival after Treatment of Canine Hemangiosarcoma with Fenofibrate
<p>Hemangiosarcoma (HSA) is a common and highly metastatic tumor that affects predominantly large-breed dogs. The median survival time for dogs diagnosed with splenic HSA without adjuvant chemotherapy after surgery is 86 days. Fenofibrate is an FDA-approved drug commonly utilized to treat high...
Shranjeno v:
Main Authors: | , , , , , |
---|---|
Format: | Knjiga |
Izdano: |
International Journal of Veterinary Science and Research - Peertechz Publications,
2015-10-16.
|
Teme: | |
Online dostop: | Connect to this object online. |
Oznake: |
Označite
Brez oznak, prvi označite!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Kopija 1 | Prosto |